Getting more Black women into cancer trials ‘not a marketing campaign, it’s a movement’news2022-02-08T15:38:05+00:00February 8th, 2022|Fierce Pharma|
Merck KGaA forms new life sciences unit in push to strengthen its CDMO positionnews2022-02-08T15:02:39+00:00February 8th, 2022|Fierce Pharma|
Azurity bags FDA nod for grape-flavored multiple sclerosis drugnews2022-02-08T14:24:01+00:00February 8th, 2022|Fierce Pharma|
CDMO Piramal earmarks $74M for upgrades to UK antibody, API manufacturing sitesnews2022-02-08T13:51:50+00:00February 8th, 2022|Fierce Pharma|
Novo Nordisk’s Wegovy passes NICE checkpoint on course to blockbusterlandnews2022-02-08T13:36:20+00:00February 8th, 2022|Fierce Pharma|
Amgen’s COVID-19 manufacturing deal with Lilly helped compensate for lagging Aimovig, Enbrel in Q4news2022-02-07T22:42:48+00:00February 7th, 2022|Fierce Pharma|
FDA must shore up plans for surprise foreign inspections, rev up hiring of overseas investigators, GAO saysnews2022-02-07T19:51:56+00:00February 7th, 2022|Fierce Pharma|
Teva forks over $150M to settle Texas opioid suitnews2022-02-07T16:33:32+00:00February 7th, 2022|Fierce Pharma|
UPDATED: Teva forks over $225M to settle Texas opioid suitnews2022-02-07T16:33:32+00:00February 7th, 2022|Fierce Pharma|
J&J, plowing ahead with talc bankruptcy strategy, faces investor push to pull product worldwidenews2022-02-07T15:47:38+00:00February 7th, 2022|Fierce Pharma|
